Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Assel
    Assel
  3. Bajorin
    Bajorin
  4. Bosl
    Bosl
  5. Carver
    Carver
  6. Feldman
    Feldman
  7. Sheinfeld
    Sheinfeld
  8. Hakimi
    Hakimi
  9. Kuo
    Kuo
  10. Pietzak
    Pietzak

Groups

  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Surgery (3)
  5. Urology (3)
  6. Survivorship Research (2)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  8. GSK Faculty (1)
  9. Sloan Kettering Institute Postdocs (1)
Search Within
  1. "Robert Motzer"
  2. "2018"
Formats
  1. Journal Article (7)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Surgery (3)
  5. Urology (3)
  6. Survivorship Research (2)

More Groups

People
  1. Robert Motzer (7)
  2. Brett Carver (2)
  3. Daniel Sjoberg (2)
  4. Darren Feldman (2)
  5. Dean Bajorin (2)
  6. George Bosl (2)

More People

Years
  1. 2018 (7)
Publications
  1. European Urology (2)
  2. Lancet Oncology (2)
  3. Urology (2)
  4. Value in Health (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomically annotated risk model for advanced renal-cell carcinoma: A retrospective cohort study
    Journal Article

    Voss, M. H.; Reising, A.; Cheng, Y.; Patel, P.; Marker, M.; Kuo, F.; Chan, T. A.; Choueiri, T. K.; Hsieh, J. J.; Hakimi, A. A.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Important group differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms in patients with metastatic renal cell carcinoma
    Journal Article

    Cella, D.; Motzer, R. J.; Rini, B. I.; Cappelleri, J. C.; Ramaswamy, K.; Hariharan, S.; Arondekar, B.; Bushmakin, A. G.
    Value in Health (2018)

    Fulltext@MSK | Save
  • Histologic and oncologic outcomes following liver mass resection with retroperitoneal lymph node dissection in patients with nonseminomatous germ cell tumor
    Journal Article

    Pietzak, E. J.; Assel, M.; Becerra, M. F.; Tennenbaum, D.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; Carver, B. S.; Sjoberg, D. D.; more...
    Urology (2018)

    Fulltext@MSK | Save
  • Elderly patients with metastatic renal cell carcinoma: Position paper from the International Society of Geriatric Oncology
    Journal Article

    Kanesvaran, R.; Le Saux, O.; Motzer, R.; Choueiri, T. K.; Scotté, F.; Bellmunt, J.; Launay-Vacher, V.
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Clinical outcome of retroperitoneal lymph node dissection after chemotherapy in patients with pure embryonal carcinoma in the orchiectomy specimen
    Journal Article

    Dowling, C. M.; Assel, M.; Musser, J. E.; Meeks, J. J.; Sjoberg, D. D.; Bosl, G.; Motzer, R.; Bajorin, D.; Feldman, D.; Carver, B. S.; more...
    Urology (2018)

    Fulltext@MSK | Save
  • Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's letter to the editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: Subgroup analyses and updated overall survival results. Eur Urol 2018;73:62–8
    Journal Article

    Motzer, R. J.; Escudier, B.; Ravaud, A.
    European Urology (2018)

    Fulltext@MSK | Save
  • Adjuvant sunitinib for high-risk renal cell carcinoma after nephrectomy: Subgroup analyses and updated overall survival results
    Journal Article

    Motzer, R. J.; Ravaud, A.; Patard, J. J.; Pandha, H. S.; George, D. J.; Patel, A.; Chang, Y. H.; Escudier, B.; Donskov, F.; Magheli, A.; more...
    European Urology (2018)

    Fulltext@MSK | Save